TP53 and cancer: Other enriched pathways include “Cellular senescence”, “MicroRNAs in cancer”, “p53 signaling pathway”, “Epstein‐Barr virus infection” and “Viral carcinogenesis”, suggesting that the DEGs are also involved in cancer‐related signalling, viral‐associated pathways and gene regulatory mechanisms.